Myriad Genetics, Inc. (MYGN) ownership: Top institutional holder: ORBIMED ADVISORS LLC ($122.88M). Insider activity: Net Buyer (19 buys, 1 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| ORBIMED ADVISORS LLC | 125000000.00 | $122.88M | 2026-03-31 |
| BlackRock Fund Advisors | 3264023.00 | $54.41M | 2016-12-31 |
| VANGUARD GROUP INC | 8225371.00 | $50.59M | 2025-12-31 |
| BlackRock, Inc. | 8889644.00 | $40.00M | 2026-03-31 |
| MILLENNIUM MANAGEMENT LLC | 6668817.00 | $30.01M | 2026-03-31 |
| GLENVIEW CAPITAL MANAGEMENT, LLC | 5411978.00 | $24.35M | 2026-03-31 |
| D. E. Shaw & Co., Inc. | 4499724.00 | $20.25M | 2026-03-31 |
| STATE STREET CORP | 4424027.00 | $19.91M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-05-14 | |
| Buy | null | 2026-05-01 | |
| Buy | null | 2026-04-14 | |
| Buy | null | 2026-04-14 | |
| Buy | null | 2026-03-22 | |
| Buy | null | 2026-03-22 | |
| Buy | null | 2026-03-22 | |
| Buy | null | 2026-03-15 |
Back to MYGN overview · MYGN earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.